Response to Kurien and Scofield: Solubility and bioavailability of curcumin

Trends in Pharmacological Sciences

Volumn 30, Issue 7, 2009, Pages 335-

  Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; CURCUMIN; LIPOSOME; TURMERIC;

AQUEOUS SOLUTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; HEAT TREATMENT; HUMAN; IN VIVO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL;

EID: 67649392466     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2009.04.006     Document Type: Letter

References (4)

1. Kurien B.T., et al. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol. 5 (2007) 567-576
2. Wang Y.J., et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15 (1997) 1867-1876
3. Antony B., et al. A pilot cross-over study to evaluate human oral bioavailability of BCM-95®CG (biocurcumax™), a novel bioenhanced preparation of curcumin. Indian J. Pharmaceutical Sci. 70 (2008) 445-450
4. Wang D., et al. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin. Cancer Res. 14 (2008) 6228-6236